Physician profile
Jeffrey Alan Wright
NPI 1003898198
$5,186.32
in general payments reported to CMS, 2019-2025
40 companies · $1,734 in 2025
The $1,734 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $607 · 2022: $465 · 2023: $870 · 2024: $1,510 · 2025: $1,734.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,114.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,363.01 | 2021-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Watchman Flx |
| Abbvie INC. | $416.12 | 2021-2025 | |
| Pfizer INC. | $329.42 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $303.83 | 2023-2025 | |
| Argenx US, INC. | $197.82 | 2024-2025 | Vyvgart Hytrulo |
| Collegium Pharmaceutical, INC. | $144.02 | 2023-2024 | Belbuca, Xtampza |
| Relievant Medsystems, INC. | $133.52 | 2022-2023 | Intracept |
| Ucb, INC. | $110.94 | 2024-2025 | Rystiggo, Zilbrysq |
| Lundbeck LLC | $109.53 | 2021-2022 | |
| Abbott Laboratories | $107.39 | 2021 | |
| Genentech USA, INC. | $99.09 | 2023-2025 | Ocrevus, Enspryng, Ocrevus Zunovo |
| Ani Pharmaceuticals, INC. | $77.23 | 2024-2025 | Purified Cortrophin Gel |
| Averitas Pharma INC. | $65.86 | 2023-2024 | Qutenza |
| Spr Therapeutics, INC | $60.79 | 2024-2025 | Sprint Pns System |
| Redhill Biopharma INC. | $56.92 | 2021-2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.